Celularity (CELUW) Return on Sales (2020 - 2025)

Celularity (CELUW) has 6 years of Return on Sales data on file, last reported at 0.06% in Q4 2025.

• Return on Sales for Q4 2025 came in at 0.06%, up 13.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.03% (down 2.0% YoY), and the FY2025 annual result was 0.03%, down 2.0% from the prior year.
• Return on Sales slipped to 0.06% in Q4 2025 per CELUW's latest filing, from 0.04% in the prior quarter.
• Over five years, Return on Sales peaked at 0.13% in Q2 2022 and troughed at 0.31% in Q1 2021.
• A 5-year average of 0.07% and a median of 0.03% in 2024 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2023: Return on Sales soared 33 bps in 2022, then declined 29 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then soared by 811 bps to 0.06% in 2022, then plunged by 87 bps to 0.01% in 2023, then sank by 2551 bps to 0.19% in 2024, then soared by 69 bps to 0.06% in 2025.
• Business Quant data shows CELUW's Return on Sales at 0.06% in Q4 2025, 0.04% in Q3 2025, and 0.04% in Q2 2025.